Mifepristone inhibits proliferation, migration and invasion of HUUA cells and promotes its apoptosis by regulation of FAK and PI3K/AKT signaling pathway

References

• HengSEvansJSalamonsenLAJoblingTWNieGThe significance of post-translational removal of α-DG-N in early stage endometrial cancer developmentOncotarget2017847819428195229137235
   PubMedGoogle Scholar
• Tejerizo-GarcíaAÁlvarez-ConejoCMuñoz-HernandoLTumor recurrence and tumor-related mortality in endometrial cancer: analysis in 276 patientsIndian J Cancer201552468268426960518
   PubMed Web of Science ®Google Scholar
• LeeNKMillsKALymanPSPromoting community-based lifestyle modification and weight management in African American endometrial cancer survivors and their female social networkGyneco-logic Oncology2015137119120
   Web of Science ®Google Scholar
• KraetschellRWFotopoulouCDowdySCRegional differences in therapy and clinical management of endometrial cancer: findings of an international survey by the North-eastern German Society of Gynaecological Oncology (NOGGO)J Clin Oncol20133115 Suppl5593
   Web of Science ®Google Scholar
• TrabertBWentzensenNFelixASYangHPShermanMEBrintonLAMetabolic syndrome and risk of endometrial cancer in the United States: a study in the SEER-medicare linked databaseCancer Epidemiol Biomarkers Prev201524126126725587111
   PubMed Web of Science ®Google Scholar
• CohenCJRahamanJEndometrial cancer. Management of high risk and recurrence including the tamoxifen controversyCancer19957610 Suppl204420528634998
   PubMed Web of Science ®Google Scholar
• CheckJHDiantonioGDiantonioADuroseauMThe progesterone receptor antagonist mifepristone does not lower serum progesterone induced blocking factor (PIBF) in the presence of progesteroneClin Exp Obstet Gynecol201643218919127132407
   PubMed Web of Science ®Google Scholar
• HeikinheimoOLeminenACacciatoreBRutanenEMKajanojaPAdvanced cervical pregnancy: uterus-sparing therapy initiated with a combination of methotrexate and mifepristone followed by evacuation and local hemostatic measuresActa Obstet Gynecol Scand200483221121214756743
   PubMed Web of Science ®Google Scholar
• LiguoriMLanariCGassHAbstract OT1-04-02: Mifepristone treatment for breast cancer patients expressing levels of progesterone receptor isoform A (PRA) higher than those of isoform B (PRB)Cancer Res2018784 SupplOT1-04-02
   Web of Science ®Google Scholar
• ZhouHJachanNSinghMAbstract 4172: Activation of AR signaling by mifepristone enhances prostate cancer growth and impairs enzalutamide responseCancer Res20177713 Suppl4172
   Web of Science ®Google Scholar
• ChenHDuanJZuoFMechanism of the reversal effect of mifepristone on drug resistance of the human cervical cancer cell line HeLa/MMCGenet Mol Res20141311288129524634186
   PubMed Web of Science ®Google Scholar
• LiuCLuQQuHDifferent dosages of mifepristone versus enantone to treat uterine fibroids: a multicenter randomized controlled trialMedicine2017967e612428207540
   PubMed Web of Science ®Google Scholar
• Carbonell EsteveJLRiverónAMCanoMMifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgeryInt J Womens Health20124758422448109
   PubMedGoogle Scholar
• EsteveJLAcostaRPérezYCamposRHernándezAVTexidóCSTreatment of uterine myoma with 5 or 10 mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trialEur J Obstet Gynecol Reprod Biol2012161220220822269473
   PubMed Web of Science ®Google Scholar
• CheckJHCheckDCohenRSarumiMMifepristone causing complete remission of rapidly advancing leukemia with measurement of progesterone-induced blocking factorAnticancer Res20143452413241624778052
   PubMed Web of Science ®Google Scholar
• RekawieckiRKowalikMKKotwicaJOnapristone (ZK299) and mifepristone (RU486) regulate the messenger RNA and protein expression levels of the progesterone receptor isoforms A and B in the bovine endometriumTheriogenology201584334835725976976
   PubMed Web of Science ®Google Scholar
• de BruinCHoflandLJNiemanLKMifepristone effects on tumor somatostatin receptor expression in two patients with Cushing’s syndrome due to ectopic adrenocorticotropin secretionJ Clin Endocrinol Metab201297245546222090282
   PubMed Web of Science ®Google Scholar
• WangYYangDSongLMifepristone-inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivoStem Cells201230216917922131096
   PubMed Web of Science ®Google Scholar
• CerlianiJPGiulianelliSSahoresAMifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasiaMedicina201070652953221163742
   PubMed Web of Science ®Google Scholar
• LiuRShiPNieZMifepristone suppresses basal triple-negative breast cancer stem cells by down-regulating KLF5 expressionTheranostics20166453354426941846
   PubMed Web of Science ®Google Scholar
• ShiPLiuWTalaMetformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradationCell Discov201731701028480051
   PubMed Web of Science ®Google Scholar
• ChenCQinJZhouZAbstract 4967: the BAP1 deubiquitinase promotes triple-negative breast cancer partially by stabilizing the KLF5 transcription factorCancer Res20157515 Suppl4967
   Web of Science ®Google Scholar
• JuradoRLópez-FloresAÁlvarez-FigueroaAGarcía-LópezPSynergistic effects of mifepristone on the cytotoxicity of cisplatin in cervical carcinoma cell lines and tumors grown in athymic miceBMC Cancer20077Suppl 1A181
   Google Scholar
• LuZZYanLZhangHLiMJZhangXHZhaoXXMifepristone inhibits the migration of endometrial cancer cells through regulating H19 methylationZhonghua Zhong Liu Za Zhi201638641127346397
   PubMedGoogle Scholar
• ParsonsJTMartinKHSlackJKTaylorJMWeedSAFocal adhesion kinase: a regulator of focal adhesion dynamics and cell movementOncogene200019495606561311114741
   PubMed Web of Science ®Google Scholar
• DeramaudtTBDujardinDNouletFAltering FAK-paxillin interactions reduces adhesion, migration and invasion processesPLoS One201493e9205924642576
   PubMed Web of Science ®Google Scholar
• DyGKYlaganLPokharelSThe prognostic significance of focal adhesion kinase expression in stage I non-small-cell lung cancerJ Thorac Oncol2014991278128425122425
   PubMed Web of Science ®Google Scholar
• TancioniIMillerNLUryuSFAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growthBreast Cancer Res20151714725880415
   PubMed Web of Science ®Google Scholar
• MoenIGebreMAlonso-CaminoVChenDEpsteinDMcDonaldDMAnti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumorsClin Exp Metastasis201532879981726445848
   PubMed Web of Science ®Google Scholar
• ChengZLiuFZhangHmiR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathwayOncotarget20178193115328415713
   PubMedGoogle Scholar
• ShiJGuoBHuiQChangPTaoKFangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAKOncol Rep2017381637028560386
   PubMed Web of Science ®Google Scholar
• ZhaoXGuanJLFocal adhesion kinase and its signaling pathways in cell migration and angiogenesisAdv Drug Deliv Rev201163861061521118706
   PubMed Web of Science ®Google Scholar
• HoJNJunWChoueRLeeJI3C and ICZ inhibit migration by suppressing the EMT process and FAK expression in breast cancer cellsMol Med Rep20137238438823179357
   PubMed Web of Science ®Google Scholar
• Taliaferro-SmithLOberlickELiuTFAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cellsOncotarget201567475725749031
   PubMedGoogle Scholar
• WilsonCNicholesKBustosDOvercoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibitionOncotarget2014517732825193862
   PubMed Web of Science ®Google Scholar
• ZhangLLiZFanYLiHLiZLiYOverexpressed GRP78 affects EMT and cell-matrix adhesion via autocrine TGF-β/Smad2/3 signalingInt J Biochem Cell Biol20156420221125934251
   PubMed Web of Science ®Google Scholar
• ZhangPBaiHLiuGMicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2Toxicol Lett2015234315116125725129
   PubMed Web of Science ®Google Scholar
• AlowayedNSalkerMSZengNSinghYLangFLEFTY2 controls migration of human endometrial cancer cells via focal adhesion kinase activity (FAK) and miRNA-200aCell Physiol Biochem201639381582627497669
   PubMedGoogle Scholar
• Goler-BaronVSladkevichIAssarafYGInhibition of the PI3K-AKT signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cellsBiochem Pharmacol201283101340134822342288
   PubMed Web of Science ®Google Scholar
• CaiQWangZQWangSHUpregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K/AKT pathwayAm J Transl Res2016810406827829993
   PubMed Web of Science ®Google Scholar
• YangSXPolleyELipkowitzSNew insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancerCancer Treat Rev201645879626995633
   PubMed Web of Science ®Google Scholar
• LianRLuBJiaoLMiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathwayEur J Pharmacol20167921627751825
   PubMed Web of Science ®Google Scholar
• LiuGSongYCuiLWenZLuXInositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential targetInt J Clin Exp Pathol201582140225973024
   PubMed Web of Science ®Google Scholar
• CasarBRimannIKatoHShattilSJQuigleyJPDeryuginaEIIn vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signalingOncogene201433225526823208492
   PubMed Web of Science ®Google Scholar
• HersIVincentEETavaréJMAkt signalling in health and diseaseCell Signal201123101515152721620960
   PubMed Web of Science ®Google Scholar
• PonnusamyMLiPFWangKUnderstanding cardiomyocyte proliferation: an insight into cell cycle activityCell Mol Life Sci20177461019103427695872
   PubMed Web of Science ®Google Scholar
• ZhangYWangBChenXLiWDongPAGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cellsOncotarget2017833547355474628903378
   PubMedGoogle Scholar
• OudartJBDouéMVautrinAThe anti-tumor NC1 domain of collagen XIX inhibits the FAK/PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interactionOncotarget2016721516152826621838
   PubMedGoogle Scholar